Cells keep collecting junk: misfolded proteins, worn membranes, mitochondria that no longer make energy. Left alone, a cell drowns in its own waste. Autophagy (literally "self-eating") is how the cell breaks its worn parts back down into amino acids and lipids and puts them back into circulation.
How a cell cleans itself out
The rough version goes like this. A double membrane forms around a damaged fragment, closes into a vesicle (the autophagosome), and fuses with a lysosome, where enzymes digest the contents. The building blocks return to the cytoplasm. There is also a targeted version: mitophagy removes specifically the defective mitochondria before they start leaking and poisoning the cell with reactive oxygen species.
This is not an emergency-only routine. A baseline level of autophagy runs all the time, and under fasting or stress it climbs sharply, because the cell's own dismantled proteins become a backup source of amino acids.
mTOR: how the cell knows it is time to clean up
The switch here is the mTOR complex (mTORC1, to be precise). When nutrients are plentiful, mTOR is active: it tells the cell to grow and build protein, and it mutes autophagy. When food is scarce, mTOR quiets down, the energy sensor AMPK kicks in, and cleanup speeds up. This is the axis that fasting, calorie restriction, and rapamycin (a pharmacological mTOR blocker) all act through.
The logic is old and simple: during a hungry stretch, a cell is better off eating its own worn-out fittings than building new ones. That regime has a side effect: more thorough housekeeping.
Autophagy and aging
The machinery weakens with age. Damaged proteins and faulty mitochondria pile up faster than the cell can take them apart, and that is one reason old tissues hold their shape less well. Loss of proteostasis and deregulated nutrient sensing both sit on the standard list of aging hallmarks, and autophagy stands at the crossing of the two.
The lifespan data are mostly from models. In yeast, the roundworm C. elegans, fruit flies, and mice, interventions that boost autophagy (fasting, rapamycin, the polyamine spermidine) extend lifespan, and knocking out the core autophagy genes abolishes the effect. In those organisms that is a strong case for a causal link. Carrying the numbers straight over to humans is premature: long controlled human trials with hard endpoints are still missing.
What can actually be measured
Autophagy is hard to "see" in a person. In the lab you look at the LC3 protein (its LC3-II form lands on the autophagosome membrane) and at p62/SQSTM1, which builds up when cleanup stalls. What matters is not a single snapshot but the flux: how much material actually passes through the lysosome per unit of time. In the clinic there are still no convenient direct biomarkers, so claims about one person's "autophagy level" are largely indirect. Worth keeping in mind when someone offers to "measure your autophagy" from a blood test.
Where research compounds come in
Autophagy clears junk inside the cell. But some cells, with age, neither die nor clean up. They enter a senescent state: they stop dividing and start leaking inflammatory signals. That is a separate problem, studied through a separate class of compounds. The senolytic peptide FOXO4-DRI, for instance, selectively triggered the death of exactly these "zombie cells" in preclinical work. And the coenzyme NAD+ is of interest because it feeds the sirtuins, enzymes that among other things influence autophagy and the cell's energy metabolism.
Both compounds in our catalog are sold as research-use-only reagents. They are not medicines, they are not meant for human consumption, and no proven doses or clinical effects in people have been established for them. Everything above is a reference overview, not medical advice; decisions about any health intervention belong with a doctor.
Research compounds from this review in our catalog: FOXO4-DRI, NAD+.
